Bitcoin's capital efficiency has sharply declined, with each bull cycle requiring exponentially more money for smaller percentage gains. This cycle has seen about $697 billion in new capital generating a 689% gain, far less than earlier cycles with smaller capital inflows but much higher returns. Analysts suggest another major rally would need over $1 trillion in fresh institutional investment, but recent ETF outflows and bitcoin's large market size raise doubts about this happening soon. The trend reflects bitcoin's growth and the challenge of attracting enough institutional money to fuel another parabolic run.
Cohu is rated a buy due to its strong position in AI and high-performance computing (HPC) chip testing, which is expected to drive significant revenue growth. Management aims for $600–800 million in revenue, 48–50% gross margin, and $1.50–$3.25 non-G...
Hyperliquid has launched a dedicated Layer-1 blockchain designed specifically for perpetual futures trading directly on-chain. This new blockchain removes the need for external bridges and introduces native order-book mechanics that operate within th...
Mirum Pharmaceuticals is rapidly growing as a leader in liver disease treatments, raising its 2026 global sales forecast to $660–$680 million due to strong performance of its drug LIVMARLI. Although recent acquisitions have delayed the company’s cash...
Nigel Farage has been reported to the UK Parliament’s standards watchdog over allegations that he lobbied the Bank of England on cryptocurrency policy in ways that could benefit Christopher Harborne, a major investor in stablecoin issuer Tether who h...
UnitedHealth Group remains a strong long-term investment despite recent operational challenges and price increases. Management targets 13–16% bottom-line growth driven by margin recovery, AI investments, and share buybacks. Current valuations suggest...
